• Je něco špatně v tomto záznamu ?

Carmellose Mucoadhesive Oral Films Containing Vermiculite/Chlorhexidine Nanocomposites as Innovative Biomaterials for Treatment of Oral Infections

J. Gajdziok, S. Holešová, J. Štembírek, E. Pazdziora, H. Landová, P. Doležel, D. Vetchý,

. 2015 ; 2015 (-) : 580146. [pub] 20150430

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16010107

Grantová podpora
NT14477 MZ0 CEP - Centrální evidence projektů

Infectious stomatitis represents the most common oral cavity ailments. Current therapy is insufficiently effective because of the short residence time of topical liquid or semisolid medical formulations. An innovative application form based on bioadhesive polymers featuring prolonged residence time on the oral mucosa may be a solution to this challenge. This formulation consists of a mucoadhesive oral film with incorporated nanocomposite biomaterial that is able to release the drug directly at the target area. This study describes the unique approach of preparing mucoadhesive oral films from carmellose with incorporating a nanotechnologically modified clay mineral intercalated with chlorhexidine. The multivariate data analysis was employed to evaluate the influence of the formulation and process variables on the properties of the medical preparation. This evaluation was complemented by testing the antimicrobial and antimycotic activity of prepared films with the aim of finding the most suitable composition for clinical application. Generally, the best results were obtained with sample containing 20 mg of chlorhexidine diacetate carried by vermiculite, with carmellose in the form of nonwoven textile in its structure. In addition to its promising physicomechanical, chemical, and mucoadhesive properties, the formulation inhibited the growth of Staphylococcus and Candida; the effect was prolonged for tens of hours.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010107
003      
CZ-PrNML
005      
20190516143720.0
007      
ta
008      
160408s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2015/580146 $2 doi
024    7_
$a 10.1155/2015/580146 $2 doi
035    __
$a (PubMed)26064926
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gajdziok, Jan $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences, Palackého Třída 1-3, 612 42 Brno, Czech Republic. $7 xx0126570
245    10
$a Carmellose Mucoadhesive Oral Films Containing Vermiculite/Chlorhexidine Nanocomposites as Innovative Biomaterials for Treatment of Oral Infections / $c J. Gajdziok, S. Holešová, J. Štembírek, E. Pazdziora, H. Landová, P. Doležel, D. Vetchý,
520    9_
$a Infectious stomatitis represents the most common oral cavity ailments. Current therapy is insufficiently effective because of the short residence time of topical liquid or semisolid medical formulations. An innovative application form based on bioadhesive polymers featuring prolonged residence time on the oral mucosa may be a solution to this challenge. This formulation consists of a mucoadhesive oral film with incorporated nanocomposite biomaterial that is able to release the drug directly at the target area. This study describes the unique approach of preparing mucoadhesive oral films from carmellose with incorporating a nanotechnologically modified clay mineral intercalated with chlorhexidine. The multivariate data analysis was employed to evaluate the influence of the formulation and process variables on the properties of the medical preparation. This evaluation was complemented by testing the antimicrobial and antimycotic activity of prepared films with the aim of finding the most suitable composition for clinical application. Generally, the best results were obtained with sample containing 20 mg of chlorhexidine diacetate carried by vermiculite, with carmellose in the form of nonwoven textile in its structure. In addition to its promising physicomechanical, chemical, and mucoadhesive properties, the formulation inhibited the growth of Staphylococcus and Candida; the effect was prolonged for tens of hours.
650    _2
$a antiinfekční látky $x aplikace a dávkování $x chemie $7 D000890
650    _2
$a biokompatibilní materiály $x aplikace a dávkování $x chemie $7 D001672
650    _2
$a sodná sůl karboxymethylcelulosy $x aplikace a dávkování $x chemie $7 D002266
650    _2
$a farmaceutická chemie $7 D002626
650    _2
$a chitosan $x chemie $7 D048271
650    _2
$a chlorhexidin $x aplikace a dávkování $x chemie $7 D002710
650    12
$a lékové transportní systémy $7 D016503
650    _2
$a lidé $7 D006801
650    _2
$a ústa $x účinky léků $x mikrobiologie $7 D009055
650    _2
$a nanokompozity $x aplikace a dávkování $x chemie $7 D053761
650    _2
$a polymery $x aplikace a dávkování $x chemie $7 D011108
650    _2
$a stomatitida $x farmakoterapie $x mikrobiologie $7 D013280
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Holešová, Sylva $u Nanotechnology Centre, VŠB-Technical University of Ostrava, 17 Listopadu 15/2172, Poruba, 708 33 Ostrava, Czech Republic ; T4Innovations Centre of Excellence, VŠB-Technical University of Ostrava, 17 Listopadu 15/2172, Poruba, 708 00 Ostrava, Czech Republic. $7 jx20080922016
700    1_
$a Štembírek, Jan $u Department of Maxillofacial Surgery, University Hospital Ostrava, 17 Listopadu 1790/5, Poruba, 708 00 Ostrava, Czech Republic. $7 xx0191600
700    1_
$a Pazdziora, Erich $u Institute of Public Health Ostrava, Centre of Clinical Laboratories, Partyzánské Náměstí 7, 702 00 Ostrava, Czech Republic. $7 xx0140962
700    1_
$a Landová, Hana $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences, Palackého Třída 1-3, 612 42 Brno, Czech Republic. $7 _AN066612
700    1_
$a Doležel, Petr $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences, Palackého Třída 1-3, 612 42 Brno, Czech Republic. $7 xx0270940
700    1_
$a Vetchý, David, $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences, Palackého Třída 1-3, 612 42 Brno, Czech Republic. $d 1972- $7 mzk2006368163
773    0_
$w MED00182164 $t BioMed research international $x 2314-6141 $g Roč. 2015, č. - (2015), s. 580146
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26064926 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20190516143828 $b ABA008
999    __
$a ok $b bmc $g 1113536 $s 934475
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 2015 $c - $d 580146 $e 20150430 $i 2314-6141 $m BioMed research international $n Biomed Res Int $x MED00182164
GRA    __
$a NT14477 $p MZ0
LZP    __
$a Pubmed-20160408

Najít záznam

Citační ukazatele

    Možnosti archivace